Korea Advanced Institute of Science and Technology professor Son Sung-min, backside; UC Berkeley professor Daniel Fletcher, left; and Gladstone Institutes Senior Vice President Melanie Ott / Courtesy of Korea Advanced Institute of Science and Technology
Scientists on the Korea Advanced Institute of Science and Technology (KAIST), in collaboration with researchers on the University of California, Berkeley and the Gladstone Institutes, have developed a brand new method that makes use of the gene-editing tool CRISPR to identify multiple pathogens without delay, the institute stated Friday.
The method, developed by KAIST professor Son Sung-min of the Department of Bio and Brain Engineering and a global group of researchers, depends on the response velocity of an enzyme often known as Cas13. By treating these variations as a “molecular barcode,” they’ll distinguish multiple viruses or micro organism in a single pattern, probably streamlining diagnostic testing for infectious illnesses.
Researchers discovered that the protein Cas13, which acts as a sensor for genetic materials, shows a singular signature when it encounters a virus. Once the protein identifies its goal, it triggers a chemical response that releases a fluorescent glow. The group found that the particular velocity of this response modifications relying on the pathogen concerned, permitting scientists to use these distinct charges of velocity as a timer to identify multiple infections without delay.
The expertise proved profitable in scientific trials, distinguishing between a number of respiratory viruses and SARS-CoV-2 variants in a single take a look at. The researchers famous that by adjusting the design of the “guide” molecules that direct the protein to its goal, they’ll fine-tune the response speeds. This flexibility permits the platform to be scaled up to identify a wider vary of pathogens.
“This research goes beyond simply detecting whether a virus is present,” Son stated. “We expect it to become a next-generation platform capable of diagnosing various infectious diseases on-site in a single test.”
Son served as first writer and co-corresponding writer on the examine.
The venture included contributions from Daniel Fletcher, a professor of bioengineering and biophysics on the University of California, Berkeley, and Melanie Ott, a professor of medication on the University of California, San Francisco and the senior vice chairman of the Gladstone Institutes.
The findings have been printed March 31 within the journal Nature Biomedical Engineering below the title “Programmable kinetic barcoding for multiplexed RNA detection with Cas13a.” The analysis was supported by KAIST’s new school settlement analysis fund and the U.S. National Institutes of Health.
This article was printed with the help of generative AI and edited by The Korea Times.